Cancer Biotherapy & Radiopharmaceuticals
Overview
Cancer Biotherapy & Radiopharmaceuticals is a peer-reviewed journal that focuses on the latest advancements in cancer treatment through biotherapy and radiopharmaceuticals. It covers a wide range of topics including targeted therapies, immunotherapy, gene therapy, and the use of radiopharmaceuticals for diagnosis and treatment. The journal provides a platform for researchers, clinicians, and industry professionals to share their findings and contribute to the field of cancer biotherapy and radiopharmaceuticals.
Details
Details
Abbr.
Cancer Biother Radiopharm
Start
1996
End
Continuing
Frequency
Bimonthly
p-ISSN
1084-9785
e-ISSN
1557-8852
Country
United States
Language
English
Specialties
Oncology
Pharmacology
Radiology
Pharmacology
Radiology
Metrics
Metrics
h-index / Ranks: 5296
68
SJR / Ranks: 7425
607
CiteScore / Ranks: 2975
6.90
JIF / Ranks: 2884
3.4
Recent Articles
1.
2.
Wang Z, Wu Z, Cheng L, Huang Q, Zhang J, Ren Y, et al.
Cancer Biother Radiopharm
. 2025 Mar;
PMID: 40067409
Lymph node metastasis (LNM) plays a critical role in the prognosis of head and neck squamous cell carcinoma (HNSCC). To enhance prognostic predictions and investigate the molecular interplay between LNM...
3.
Daungsupawong H, Wiwanitkit V
Cancer Biother Radiopharm
. 2025 Mar;
PMID: 40067408
No abstract available.
4.
Khoshbakht S, Zare S, Khatuni M, Ghodsirad M, Bayat M, Mirabootalebi F, et al.
Cancer Biother Radiopharm
. 2025 Mar;
PMID: 40040519
Differentiating purely viral from bacterial etiologies continues to be a challenging yet key step in the management of community-acquired pneumonia (CAP), further highlighted since the COVID-19 pandemic. This study aims...
5.
Schatzmann A, Stallons T, Rivera R, Nguyen Q, Dureau R, Torgue J
Cancer Biother Radiopharm
. 2025 Feb;
PMID: 40019794
The cytotoxic effect of Pb on microbial growth was examined, using six microorganisms, at clinically relevant time points, to determine the potency of Pb as a self-sterilizing agent in radiopharmaceuticals...
6.
Madru R, Larsson E, Orbom A, Ingvar C, Grabau D, Knutsson L, et al.
Cancer Biother Radiopharm
. 2025 Feb;
PMID: 40000017
For breast cancer staging, radiolabeled colloids and superparamagnetic iron oxide nanoparticles (SPIONs) are used for sentinel lymph node (SLN) imaging. This study characterized the intranodal activity distribution and absorbed dose...
7.
Wang N, Mei X, Cao Y, Wang L, Xie H, Jia J, et al.
Cancer Biother Radiopharm
. 2025 Feb;
PMID: 40000014
Nab-paclitaxel effectively inhibits tumor proliferation and modulates macrophage polarization to improve the tumor microenvironment. However, its potential to achieve radiosensitization in cholangiocarcinoma remains to be elucidated. The proliferation inhibition and...
8.
Turner J
Cancer Biother Radiopharm
. 2025 Feb;
PMID: 39973351
Deep learning artificial intelligence (AI) algorithms are poised to subsume diagnostic imaging specialists in radiology and nuclear medicine, where radiomics can consistently outperform human analysis and reporting capability, and do...
9.
Zhi Y, Zhang W, Wu Z, Chen Y, Feng L, He J, et al.
Cancer Biother Radiopharm
. 2025 Feb;
PMID: 39914820
The abnormal expression of kinase family member 4A () is linked to breast cancer progression, with numerous miRNAs exhibiting abnormal expression. Thus, there is an urgent need to investigate the...
10.
Ward C, Scott S, Wesson W, Mazurek J, Kozlowski I, Werner G, et al.
Cancer Biother Radiopharm
. 2025 Jan;
PMID: 39879533
To evaluate the use of yttrium-90 (Y90) dosimetry in predicting treatment outcomes when used following transarterial radioembolization with SIR-Spheres® (Resin Y90) in patients with hepatic tumors. This single institution retrospective...